Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement
Open Access
- 8 August 2024
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 50 (9) , 1426-1437
Abstract
Purpose Novel interventions for the prevention or treatment of acute kidney injury (AKI) are currently lacking. To facilitate the evaluation and adoption of new treatments, the use of the most appropriate design and endpoints for clinical trials in AKI is critical and yet there is little consensus regarding these issues. We aimed to develop recommendations on endpoints and trial design for studies of AKI prevention and treatment interventions based on existing data and expert consensus. Methods At the 31st Acute Disease Quality Initiative (ADQI) meeting, international experts in critical care, nephrology, involving adults and pediatrics, biostatistics and people with lived experience (PWLE) were assembled. We focused on four main areas: (1) patient enrichment strategies, (2) prevention and attenuation studies, (3) treatment studies, and (4) innovative trial designs of studies other than traditional (parallel arm or cluster) randomized controlled trials. Using a modified Delphi process, recommendations and consensus statements were developed based on existing data, with > 90% agreement among panel members required for final adoption. Results The panel developed 12 consensus statements for clinical trial endpoints, application of enrichment strategies where appropriate, and inclusion of PWLE to inform trial designs. Innovative trial designs were also considered. Conclusion The current lack of specific therapy for prevention or treatment of AKI demands refinement of future clinical trial design. Here we report the consensus findings of the 31st ADQI group meeting which has attempted to address these issues including the use of predictive and prognostic enrichment strategies to enable appropriate patient selection.Keywords
Funding Information
- Universitätsklinikum Münster
This publication has 74 references indexed in Scilit:
- New drugs for acute kidney injuryIntensive Care Medicine, 2022
- Patient-Reported Outcome Measures in Clinical ResearchJAMA, 2022
- Predictive Accuracy of a Perioperative Laboratory Test–Based Prediction Model for Moderate to Severe Acute Kidney Injury After Cardiac SurgeryJAMA, 2022
- Randomised clinical trials in critical care: past, present and futureIntensive Care Medicine, 2021
- Derivation and External Validation of a Risk Index for Predicting Acute Kidney Injury Requiring Kidney Replacement Therapy After Noncardiac SurgeryJAMA Network Open, 2021
- Internal and External Validation of a Machine Learning Risk Score for Acute Kidney InjuryJAMA Network Open, 2020
- Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical VentilationJAMA, 2020
- Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney InjuryJAMA, 2018
- Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney InjuryJAMA, 2017
- Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trialIntensive Care Medicine, 2017